CVD Equipment Announces SuperPower Took Delivery of Second Reel-to-Reel MOCVD Deposition System

CVD Equipment Corporation (CVD) (NASDAQ: CVV), announced today that SuperPower, Inc., a wholly owned subsidiary of Royal Philips Electronics N.V., took delivery of a second Reel-to-Reel MOCVD deposition system for the production of its second-generation high temperature superconductor (2G HTS) wire that is being provided to organizations around the world for application to products in the fields of energy and medical technologies, transportation, science and research, space, military and general industry. The custom-designed system, built in the Company's Long Island, NY manufacturing center, employs an advanced, reel-to-reel material handling system and precise metal organic chemical vapor deposition (MOCVD) chamber. SuperPower deposits a complex superconducting film on a metal tape, producing a "wire" which is then wound into superconducting cables, coils, and other components that enable a variety of energy-efficient and high-performance devices such as power transmission cable systems, transformers, motors, generators, fault current limiters, and magnets.

SuperPower recognized the need for a major CVD solution provider in order to get a system capable of depositing its proprietary MOCVD film at high temperatures and high throughput for the critical film thicknesses and material properties needed for these advanced energy delivery systems. John Dackow, SuperPower Director of Operations said "After exhaustive review, CVD was selected to provide our first MOCVD system because we needed a partner who could both think creatively about overall system design, and provide the necessary MOCVD process and system know-how to deliver on our challenging specifications. After taking delivery of the first unit in 2004, it was clear that we had made the right choice. The selection of CVD to provide the follow-on unit was without question."

"We could not be more pleased with the statement that SuperPower is making with this second delivery," said Michael J. Gray, CVD's VP of Sales and Marketing. "As a company with a long history of providing instrumentation for groundbreaking scientific achievement, CVD is always focused on ways to accelerate our customers' paths to commercialization. Having delivered this kind of support to SuperPower, they have now rewarded us with repeat business. We expect further follow-on orders as SuperPower's market penetration expands."

"CVD is never satisfied with being just another CVD tool supplier," said Len Rosenbaum, CVD Equipment's Founder and CEO. "It has always been our ardent desire to be a partner in our customers' success. We believed in what we saw at SuperPower from the beginning. Now that their path to commercialization has reached the next level, we continue to be right there to support them. We are very proud to be a part of such novel technology once again, and we expect to be able to apply technology developed for SuperPower to next generation thin film solar module manufacturing as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CVD Equipment Corporation. (2019, March 18). CVD Equipment Announces SuperPower Took Delivery of Second Reel-to-Reel MOCVD Deposition System. AZoNano. Retrieved on December 11, 2024 from https://www.azonano.com/news.aspx?newsID=14259.

  • MLA

    CVD Equipment Corporation. "CVD Equipment Announces SuperPower Took Delivery of Second Reel-to-Reel MOCVD Deposition System". AZoNano. 11 December 2024. <https://www.azonano.com/news.aspx?newsID=14259>.

  • Chicago

    CVD Equipment Corporation. "CVD Equipment Announces SuperPower Took Delivery of Second Reel-to-Reel MOCVD Deposition System". AZoNano. https://www.azonano.com/news.aspx?newsID=14259. (accessed December 11, 2024).

  • Harvard

    CVD Equipment Corporation. 2019. CVD Equipment Announces SuperPower Took Delivery of Second Reel-to-Reel MOCVD Deposition System. AZoNano, viewed 11 December 2024, https://www.azonano.com/news.aspx?newsID=14259.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.